Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZLAB compared with XPEV: revenue, margins and what each company keeps, and the suppliers and customers both name
ZLAB
Zai Lab Ltd
Change
Mkt cap
Revenue
Revenue
XPEV
Xpeng Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZLAB
Zai Lab Ltd
vs
XPEV
Xpeng Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ZLAB
Zai Lab Ltd
Change
22.09
▼
−1.21%
· post 22.10
Mkt cap
$2.5B
Revenue
$106M
Q2 FY26
Revenue
$460M
FY25
XPEV
Xpeng Inc.
Change
9.03
▼
−1.69%
· post 9.00
Closed
Oct 30 '26
Mkt cap
$8.6B
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
ZLAB
Zai Lab Ltd
vs
XPEV
Xpeng Inc.
22.09
▼
−1.21%
post 22.10
Price
9.03
▼
−1.69%
post 9.00
$2.5B
Mkt cap
$8.6B
Q2 FY26
$106M
Revenue
—
FY25
$460M
Revenue
—
Change
Change
ZLAB
22.09
▼
−1.21%
vs
XPEV
9.03
▼
−1.69%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ZLAB: latest quarter is a loss; flow not drawable. XPEV: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ZLAB
9
PFE
Pfizer
supplier
VRTX
Vertex Pharmaceuticals
supplier
BMY
Bristol-Myers Squibb
supplier
INVA
Innoviva
supplier
5 more · ZLAB chain
›
Shared
0
No shared counterparties.
Only XPEV
2
ADNT
Adient
supplier
—
DiDi
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ZLAB, solid
XPEV, dashed